Fusion-oncogenes are associated with increased metastatic capacity and persistent disease in pediatric thyroid cancers
Aime T. Franco, Julio C. Ricarte-Filho, Amber R. Isaza, Zachary Jones, Neil K. Jain, Sogol Mostoufi‐Moab, Lea F. Surrey, Theodore Willis Laetsch, Marilyn M. Li, Jessica Clague DeHart, Erin Reichenberger, Deanne Taylor, Ken Kazahaya, N. Scott Adzick, Andrew J. Bauer
This study shows that genetic subtypes of pediatric thyroid cancer, particularly RET/NTRK fusions, are linked to worse clinical outcomes compared to RAS- or BRAF-mutant subtypes.
Journal of Clinical Oncology · Jan 11, 2022Peer-reviewedGenetics